Partnership leverages AI-powered genome design to optimize AAV constructs, accelerate lead candidate selection, and improve drug substance manufacturability for rare and ultra-rare neuromuscular ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback